Identification of differentially expressed genes in human bladder cancer through genome-wide gene expression profiling

Oncology Reports

Volumn 16, Issue 3, 2006, Pages 521-531

  Kawakami, Kazumori ^a,b   Enokida, Hideki ^a   Tachiwada, Tokushi ^a   Gotanda, Takenari ^a   Tsuneyoshi, Kengo ^a   Kubo, Hiroyuki ^a   Nishiyama, Kenryu ^a   Takiguchi, Masaki ^b   Nakagawa, Masayuki ^a   Seki, Naohiko ^b  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Bladder cancer; CKS2; Expression profile; Microarray

Indexed keywords

MESSENGER RNA; TUMOR MARKER; TUMOR PROTEIN;

AGED; ARTICLE; BLADDER TUMOR; CANCER INVASION; DISEASE COURSE; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; GENOME; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 33749183595     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.16.3.521     Document Type: Article

References (33)

1. Jemal A, Murray T, Ward E, et al: Cancer statistics, 2005. CA Cancer J Clin 55: 10-30, 2005. (Pubitemid 40310185)
2. Al-Sukhun S and Hussain M: Molecular biology of transitional cell carcinoma. Crit Rev Oncol Hematol 47: 181-193, 2003. (Pubitemid 36957861)
3. Dyrskjot L, Thykjaer T, Kruhoffer M, et al: Identifying distinct classes of bladder carcinoma using microarrays. Nat Genet 33: 90-96, 2003. (Pubitemid 36068689)
4. Modlich O, Prisack HB, Pitschke G, et al: Identifying superficial, muscle-invasive, and metastasizing transitional cell carcinoma of the bladder: Use of cDNA array analysis of gene expression profiles. Clin Cancer Res 10: 3410-3421, 2004. (Pubitemid 38685447)
5. Knowles MA: What we could do now: Molecular pathology of bladder cancer. Mol Pathol 54: 215-221, 2001. (Pubitemid 32730394)
6. Giannopoulos A, Manousakas T, Gounari A, Constantinides C, Choremi-Papadopoulou H and Dimopoulos C: Comparative evaluation of the diagnostic performance of the BTA stat test, NMP22 and urinary bladder cancer antigen for primary and recurrent bladder tumors. J Urol 166: 470-475, 2001. (Pubitemid 32652225)
7. Mahnert B, Tauber S, Kriegmair M, et al: Measurements of complement factor H-related protein (BTA-TRAK assay) and nuclear matrix protein (NMP22 assay) - useful diagnostic tools in the diagnosis of urinary bladder cancer? Clin Chem Lab Med 41: 104-110, 2003. (Pubitemid 36285393)
8. Ogawa K, Utsunomiya T, Mimori K, et al: Genomic screens for genes upregulated by demethylation in colorectal cancer: possible usefulness for clinical application. Int J Oncol 27: 417-426, 2005.
9. Nishidate T, Katagiri T, Lin ML, et al. Genome-wide gene-expression profiles of breast-cancer cells purified with laser microbeam microdissection: identification of genes associated with progression and metastasis. Int J Oncol 25: 797-819, 2004.
10. Lee BC, Cha K, Avraham S and Avraham HK: Microarray analysis of differentially expressed genes associated with human ovarian cancer. Int J Oncol 24: 847-851, 2004.
11. Sanchez-Carbayo M, Socci ND, Lozano JJ, et al: Gene discovery in bladder cancer progression using cDNA microarrays. Am J Pathol 163: 505-516, 2003. (Pubitemid 36909413)
12. Dyrskjot L, Kruhoffer M, Thykjaer T, et al: Gene expression in the urinary bladder: a common carcinoma in situ gene expression signature exists disregarding histopathological classification. Cancer Res 64: 4040-4048, 2004. (Pubitemid 38697320)
13. Thykjaer T, Workman C, Kruhoffer M, et al: Identification of gene expression patterns in superficial and invasive human bladder cancer. Cancer Res 61: 2492-2499, 2001. (Pubitemid 32685829)
14. Wild PJ, Herr A, Wissmann C, et al: Gene expression profiling of progressive papillary noninvasive carcinomas of the urinary bladder. Clin Cancer Res 11: 4415-4429, 2005. (Pubitemid 40825632)
15. Blaveri E, Simko JP, Korkola JE, et al: Bladder cancer outcome and subtype classification by gene expression. Clin Cancer Res 11: 4044-4055, 2005. (Pubitemid 40791568)
16. Sobin LH and Wittekind C: TNM classification of malignant tumours. In: International Union Against Cancer (UICC). 5th edition. Wiley-Liss Publications, New York, pp188-190, 1997.
17. The Japanese Urological Association and the Japanese Society of Pathology: General Rules for Clinical and Pathological Studies on Bladder Cancer. 2nd edition. Kanehara Publishing Co., Tokyo, p80, 1993.
18. Arai M, Yokosuka O, Fukai K, et al: Gene expression profiles in liver regeneration with oval cell induction. Biochem Biophys Res Commun 317: 370-376, 2004. (Pubitemid 38452492)
19. Prat E, Bernues M, Caballin MR, Egozcue J, Gelabert A and Miro R: Detection of chromosomal imbalances in papillary bladder tumors by comparative genomic hybridization. Urology 57: 986-992, 2001. (Pubitemid 32405331)
20. Simon R, Burger H, Semjonow A, Hertle L, Terpe HJ and Bocker W: Patterns of chromosomal imbalances in muscle invasive bladder cancer. Int J Oncol 17: 1025-1029, 2000.
21. Richter J, Beffa L, Wagner U et al: Patterns of chromosomal imbalances in advanced urinary bladder cancer detected by comparative genomic hybridization. Am J Pathol 53: 1615-1621, 1998. (Pubitemid 28509919)
22. Kawamura T, Kanno R, Fujii H and Suzuki T: Expression of liver-type fatty-acid-binding protein, fatty acid synthase and vascular endothelial growth factor in human lung carcinoma. Pathobiology 72: 233-240, 2005. (Pubitemid 43004466)
23. Fujii K, Kondo T, Yokoo H, et al: Proteomic study of human hepatocellular carcinoma using two-dimensional difference gel electrophoresis with saturation cysteine dye. Proteomics 5: 1411-1422, 2005.
24. Kuhn U and Wahle E: Structure and function of poly(A) binding proteins. Biochim Biophys Acta 25: 67-84, 2004. (Pubitemid 38626168)
25. Van Duin M, van Marion R, Vissers K, et al: High-resolution array comparative genomic hybridization of chromosome arm 8q: evaluation of genetic progression markers for prostate cancer. Genes Chromosomes Cancer 44: 438-439. 2005.
26. Li M, Lin YM, Hasegawa S, et al: Genes associated with liver metastasis of colon cancer, identified by genome-wide cDNA microarray. Int J Oncol 24: 305-312, 2004.
27. Urbanowicz-Kachnowicz I, Baghdassarian N, Nakache C, et al: ckshs expression is linked to cell proliferation in normal and malignant human lymphoid cells. Int J Cancer 82: 98-104, 1999. (Pubitemid 29266113)
28. Golas MM, Sander B, Will CL, et al: Molecular architecture of the multiprotein splicing factor SF3b. Science 300: 980-984, 2003. (Pubitemid 36548885)
29. Ford MJ, Anton IA and Lane DP: Nuclear protein with sequence homology to translation initiation factor eIF-4A. Nature 332: 736-78, 1988.
30. Hirling H, Scheffner M and Restle T: RNA helicase activity associated with the human p68 protein. Nature 339: 562-564, 1989. (Pubitemid 19152100)
31. Causevic M, Hislop RG, Kernohan NM, et al: Overexpression and poly-ubiquitylation of the DEAD-box RNA helicase p68 in colorectal tumours. Oncogene 20: 7734-7743, 2001. (Pubitemid 33121946)
32. Marchetti A, Buttitta F, Miyazaki S, et al: Int-6, a highly conserved, widely expressed gene, is mutated by mouse mammary tumor virus in mammary preneoplasia. J Virol 69: 1932-1938, 1995.
33. Buttitta F, Martella C, Barassi F, et al: Int6 expression can predict survival in early-stage non-small cell lung cancer patients. Clin Cancer Res 11: 3198-3204, 2005. (Pubitemid 40627865)